Medtronic Expects Fiscal Year 2025 Organic Revenue Growth Of 4%-5%
Portfolio Pulse from Benzinga Newsdesk
Medtronic has announced its expectation for fiscal year 2025 organic revenue growth to be between 4% and 5%.
May 23, 2024 | 10:52 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Medtronic has announced its expectation for fiscal year 2025 organic revenue growth to be between 4% and 5%.
The announcement of expected revenue growth is a positive indicator for Medtronic's future performance. Investors may view this as a sign of strong business prospects, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100